Abstract About one-third of mammalian proteins are secreted proteins and membrane proteins. Most of these proteins contain disulfide bonds in their native state, covalent links formed between the thiol groups of cysteine residues. In many proteins, disulfide bonds play an essential role in folding, stabilizing structure and the function of the protein. Therefore, understanding the pathways of disulfide bond formation is crucial for a wide range of medical processes and therapies. Disulfide bond formation is catalyzed by the Protein Disulfide Isomerase (PDI) family. To date the mechanisms of the PDIs in disulfide bond formation and pathways for disulfide bond formation have not been fully characterized. Here the structure of the substrate binding <b>b’x</b> domain of human PDI was determined. The structure shows that the<b> b'</b> domain has a typical thioredoxin fold and that the <b>x</b> region can interact with the substrate binding site of the <b>b'</b> domain. Specifically, the <b>x</b> region of PDI can adopt alternative conformations during the functional cycle of PDI action and that these are linked to the ability of PDI to interact with folding substrates. In addition, this study showed that two human proteins, GPx7 and GPx8 are involved in disulfide bond formation. The addition of GPx7 or GPx8 to a folding protein along with PDI and peroxide allows the efficient oxidative refolding of a reduced denatured substrate protein. Finally, this thesis includes the development of a system for the efficient production of disulfide bond containing proteins in the cytoplasm of E. coli. It showed that the introduction of Erv1p, a sulfhydryl oxidase and FAD-dependent catalyst of disulfide bond, allows the formation of native disulfide bonds in the cytoplasm of E. coli even without the disruption of genes involved in disulfide bond reduction. Introduction of Erv1p and a disulfide isomerase, e.g. PDI, allows the efficient formation of natively folded eukaryotic proteins with multiple disulfide bonds in the cytoplasm of E. coli. This system is able to express high levels of complex disulfide bonded eukaryotic proteins. / Tiivistelmä Noin kolmasosa kaikista nisäkkäiden proteiineista on solun ulkopuolelle eritettäviä proteiineja ja kalvoproteiineja. Monet näistä proteiineista sisältävät natiivissa konformaatiossaan disulfidisidoksia, jotka ovat kovalenttisia sidoksia kysteiinitähteiden tioliryhmien välillä. Useissa proteiineissa näillä disulfidisidoksilla on keskeinen rooli proteiinin laskostumisessa, kolmiulotteisen rakenteen stabiloinnissa sekä proteiinin toiminnassa. Disulfidisidosten muodostumisen taustalla olevien mekanismien tunteminen onkin tärkeää monien lääketieteellisten prosessien ja hoitomenetelmien kannalta. Disulfidisidosten muodostumista katalysoivat proteiinidisulfidi-isomeraasi (PDI) -perheeseen kuuluvat entsyymit. PDI entsyymien toimintamekanismeja ja disulfidisidosten muodostumisen reaktioreittejä ei kuitenkaan vielä tunneta tarkasti. Tässä väitöskirjassa selvitettiin ihmisen PDI entsyymin substraattia sitovan <b>b’x</b> alayksikön rakenne. Rakenteesta voidaan todeta <b>b’</b> alayksikön laskostuminen tyypilliseen tioredoksiini muotoon sekä <b>x</b> alueen interaktio <b>b’</b> alayksikön substraattia sitovan kohdan kanssa. PDI entsyymin katalysoiman reaktioketjun aikana <b>x</b> alayksikkö voi muuttaa konformaatiotaan mahdollistaen PDI entsyymin interaktion laskostuvien substraattiproteiinien kanssa. Tässä tutkimuksessa osoitettiin myös kahden ihmisen proteiinin, GPx7 ja GPx8 osallistuminen disulfidisidosten muodostumista katalysoiviin reaktioihin. GPx7 ja GPx8 entsyymien lisäys laskostumisreaktioon yhdessä PDI:n ja vetyperoksidin kanssa mahdollistaa pelkistetyn, denaturoidun substraattiproteiinin tehokkaan, hapettaviin reaktioihin perustuvan uudelleenlaskostumisen natiiviin muotoonsa. Osana tätä väitöstutkimusta kehitettiin menetelmä, joka mahdollistaa disulfideja sisältävien proteiinien tehokkaan tuoton E.colin solulimassa. Menetelmässä sulfhydryylioksidaasina ja FAD:sta riippuvana disulfidisidosten muodostumisen katalysaattorina toimiva Erv1p mahdollistaa disulfidisidosten muodostumisen E.colin solulimassa myös ilman solun pelkistävien reaktioreittien geneettistä poistamista. Erv1p yhdessä disulfidi-isomeraasin, kuten PDI, kanssa mahdollistaa oikein laskostuneiden, useita disulfidisidoksia sisältävien eukaryoottisten proteiinien tehokkaan tuotannon E.colin solulimassa. Menetelmällä pystytään tuottamaan suuria määriä monimutkaisia disulfidisidoksellisia proteiineja.

Among the peptidyl prolyl isomerases, the Cyclophilin family of proteins has been linked to various cellular activities such as regulation of homeostasis, mitochondrial permeability, and cell death. Their functionality spans throughout the cell and throughout all cell types as different isoforms. Previous studies done on Cyclophilin A revealed an interesting contact ensemble when bound to a substrate. Because of the similarity of CypA to its homologues, it is believed that they too will exhibit the same contact dynamics. We have defined the dynamics of cyclophilin isoforms through Molecular Dynamics simulations and determined their contact dynamics, characterizing their contact ensembles, and their relative dynamical conservation to each other.

No description available.

No description available.

No description available.

Hydrogen production from abundant renewable biomass would decrease reliance on crude oils, achieve nearly zero net greenhouse gas emissions, create more jobs, and enhance national energy security. Cell-free synthetic pathway biotransformation (SyPaB) is the implementation of complicated chemical reaction by the in vitro assembly of numerous enzymes and coenzymes that microbes cannot do. One of the largest challenges is the high cost and instability of enzymes and cofactors. To overcome this obstacle, strong motivations have driven intensive efforts in discovering, engineering, and producing thermostable enzymes. In this project, ribose-5-phosphate isomerase (RpiB), one of the most important enzymes in the pentose phosphate pathway, was cloned from a thermophile Thermotoga maritima, and heterologously expressed in Escherichia coli, purified and characterized. High-purity RpiB was obtained by heat pretreatment through its optimization in buffer choice, buffer pH, as well as temperature and duration of pretreatment. This enzyme had the maximum activity at 80°C and pH 6.5-8.0. It had a half lifetime of 71 h at 60°C, resulting in its turn-over number of more than 2 x108 mol of product per mol of enzyme. Another two thermostable enzymes glucose-6-phosphate dehydrogenase (G6PDH) and diaphorase (DI) and their fusion proteins G6PDH-DI and DI-G6PDH were cloned from Geobacillus stearothermophilus, heterologouely expressed in E. coli and purified through its His-tag. The individual proteins G6PDH and DI have good thermostability and reactivity. However, the presence of DI in fusion proteins drastically decreased G6DPH activity. However, a mixture of G6PDH and a fusion protein G6PDH-DI not only restored G6PDH activity through the formation of heteromultimeric network but also facilitated substrate channeling between DI and G6PDH, especially at low enzyme concentrations. My researches would provide important building blocks for the on-going projects: high-yield hydrogen production through cell-free enzymatic pathways and electrical energy production through enzymatic fuel cells. / Master of Science

Les aldose-cétose isomérases sont des enzymes catalysant l’isomérisation réversible entre un aldose et un cétose. Nous avons étudiés trois d’entre-elles : les phosphoribose isomérases (RPI), les phosphomannose isomérases (PMI) et les phosphoglucose isomérases (PGI). Ces enzymes interviennent dans différentes voies métaboliques comme la glycolyse, la néoglucogenèse, la voie des pentoses phosphates ou le métabolisme du mannose. Il a été montré qu’elles jouent un rôle important pour assurer la survie et le développement de plusieurs parasites responsables de maladies comme la leishmaniose, la mucoviscidose, la tuberculose, le paludisme ou la maladie du sommeil. Ces enzymes sont donc des cibles thérapeutiques potentielles. Ainsi, les puissants inhibiteurs de ces enzymes peuvent donc être des agents thérapeutiques efficaces pour combattre ces maladies. Les réactions catalysées par ces enzymes impliquent des intermédiaires de haute énergie (IHE) de type 1,2-cis-ènediol(ate). La synthèse d’analogues de ces intermédiaires a permis d’obtenir au laboratoire, les meilleurs inhibiteurs connus de ces enzymes, l’acide 5-phospho-D-arabononohydroxamique (5PAH, meilleur inhibiteur des PMI et PGI) et le 5-phospho-D-ribonate (5PRA, meilleur inhibiteur des RPI). Cependant, ces inhibiteurs possèdent une fonction phosphate facilement hydrolysable en milieu physiologique. Ce qui les rend inactifs in vivo. Au cours de ce travail de thèse, des phosphoanalogues du 5PAH, du 5-phospho-D-ribose (R5P, le substrat des RPI) et du 5PRA possédant une fonction malonate, phosphonate, phosphorothiate, sulfate et sulfonate à la place de la fonction phosphate ont été obtenus par des voies de synthèse multi-étapes faisant intervenir le D-arabinose ou le D-ribose comme produit de départ. Les propriétés inhibitrices de ces composés ont ensuite été déterminées et leur stabilité en milieu physiologique évaluée. Le phosphoanalogue du 5PAH de type malonate, l’acide 5-désoxy-5-dicarboxyméthyl-D-arabinonohydroxamique (5DCAH) est un inhibiteur moyen et stable de la PMI d’Escherichia Coli. Parmi les phosphoanalogues du R5P, les composés de type sulfate et sulfonate, respectivement, le 5-sulfate-D-ribose (5SR) et 5-désoxy-5-sulfonométhyl-D-ribose (5SMR) sont de bons inhibiteurs de trois RPI (la RPI d’épinard, la RPI d’Escherichia Coli et la RPI de Micobacterium tuberculosis). Seul le composé de type sulfonate est stable en milieu physiologique. Le phosphoanalogue de type malonate, le 5-désoxy-5-dicarboxyméthyl-D-ribose (5DCR) est un inhibiteur moyen de ces trois RPI. En revanche, les phosphoanalogues de type phosphorothioate et phosphonate, respectivement, le 5-désoxy-5-phosphorothioate-D-ribose (5PTR) et 5-désoxy-5-phosphonométhyl-D-ribose (5PMR) sont de mauvais inhibiteurs. Le phosphoanalogue de type phosphonate du 5PRA, le 5-désoxy-5-phosphonométhyl-D-ribonate (5PMRA) est un bon inhibiteur de la RPI de Micobacterium tuberculosis. De plus, ce composé est stable en milieu physiologique. Il est en revanche un mauvais inhibiteur de la RPI d’épinard et d’Escherichia Coli. Ces résultats sont particulièrement prometteurs puisque le 5PMRA est à ce jour le meilleur inhibiteur stable et spécifique de la RPI de Micobacterium tuberculosis. / Aldose-ketose isomerases are enzymes which catalyze the interconversion of an aldose and a ketose. We have studied three of them: phosphoribose isomerase (RPI), phosphomannose isomerase (PMI) and phosphoglucose isomerase (PGI). These enzymes play a major role in various metabolic pathways as glycolysis, neoglucogenesis, the pentoses phosphates pathways or the mannose metabolism. It has been shown to have a crucial role for the survival and development of several microorganisms responsible for diseases as the leishmaniose, the cystic fibrosis, the tuberculosis, the malaria or the insomnia. These enzymes are thus potential therapeutic targets. Consequently, strong inhibitors of these enzymes could provide efficient therapeutic tools against these deseases. The reactions catalyzed by these enzymes involve intermediaries of high energy (IHE) of 1,2-cis-enediol(ate) type. The synthesis of analogues of these intermediaries allowed to obtain in the laboratory, the best inhibitors known for these enzymes, the acid 5-phospho-D-arabononohydroxamique (5PAH, the best inhibitor of the PMI and PGI) and the 5-phospho-D-ribonate (5PRA, the best inhibitor of the RPI). However, these inhibitors possess a phosphate group which is easily hydrolysable in physiological environment, what makes them inactive in vivo. During this work of thesis, phosphoanalogues of the 5PAH, the 5-phospho-D-ribose (R5P, the substrate of the RPI) and of the 5PRA possessing a malonate, phosphonate, phosphorothiate, sulphate and sulfonate were obtained by multi-steps synthesis bringing in D-arabinose or D-ribose as starting product. The inhibitive properties of these compounds were then determined and their stability in physiological environment evaluated. The phosphoanalogue of the 5PAH of malonate type, the acid 5-desoxy-5-dicarboxyméthyl-D-arabinonohydroxamique (5DCAH) is a modest and stable inhibitor of the PMI of Escherichia Coli. Among the phosphoanalogues of the R5P, the compounds of sulphate and sulfonate types, respectively, the 5-sulfate-D-ribose (5SR) and 5-desoxy-sulfonomethyl-D-ribose (5SMR), are good inhibitors of three RPI (the RPI of spinach, the RPI of Escherichia Coli and the RPI of Micobacterium tuberculosis). Only the compound of sulfonate type is stable in physiological environment. The phosphoanalogue of malonate type, the 5-desoxy-5-dicarboxymethyl-D-ribose (5DCR) is a modest inhibitor of this three RPI. On the other hand, the phosphoanalogues of phosphorothioate and phosphonate types, respectively, the 5-desoxy-5-phosphorothioate-D-ribose (5PTR) and the 5-desoxy-5-phosphonomethyl-D-ribose (5PMR), are bad inhibitors. The phosphoanalogue of phosphonate type of the 5PRA, the 5-desoxy-5-phosphonomethyl-D-ribonate (5PMRA), is a good inhibitor of the RPI of Micobacterium tuberculosis. Furthermore, this compound is stable in physiological environment. It is on the other hand a bad inhibitor of the RPI of spinach and Escherichia Coli. These results are particularly promising because the 5PMRA is this day the best stable and specific inhibitor of the RPI of Micobacterium tuberculosis.

Sulfiredoxin (Srx) is an antioxidant enzyme that can be induced by oxidative stress. It promotes oncogenic phenotypes of cell proliferation, colony formation, migration, and metastasis in lung, skin and colon cancers. Srx reduces the overoxidation of 2-cysteine peroxiredoxins in cells, in addition to its role of removing glutathione modification from several proteins. In this study, I explored additional physiological functions of Srx in lung cancer through studying its interacting proteins. Protein disulfide isomerase (PDI) family members, thioredoxin domain containing protein 5 (TXNDC5) and protein disulfide isomerase family A member 6 (PDIA6), were detected to interact with Srx. Therefore, I proposed that TXNDC5 and PDIA6 are important for the oncogenic phenotypes of Srx in lung cancer. In chapter one, I presented background information about the role of Srx as an antioxidant enzyme in cancer. I also explained the functional significance of PDIs as oxidoreductase and chaperones in cells. In chapter two, I verified the Srx-TXNDC5/PDIA6 interaction in HEK293T and A549 cells by co-immunoprecipitation and other assays. In TXNDC5 and PDIA6, the N-terminal thioredoxin-like domain (D1) is determined to be the main platform for interaction with Srx. The Srx-TXNDC5 interaction was enhanced by H2O2 treatment in A549 cells. Srx was determined to localize in the endoplasmic reticulum (ER) of A549 cells along with TXNDC5 and PDIA6. This localization was confirmed by both subcellular fractionation and immunofluorescence imaging experiments. In chapter three I focused on studying the physiological function of Srx interacting proteins in the ER. A549 subcellular fractionation results showed that TXNDC5 facilitates Srx retention in the ER. Moreover, TXNDC5 and Srx were found to participate in chaperone activities in lung cancer. Both proteins contributed in the refolding of heat-shock induced protein aggregates. In addition, TXNDC5 and PDIA6 were found to enhance the protein refolding in response to H2O2 treatment. Conversely, Srx appeared to have an inhibitory effect on protein folding under same treatment conditions. Downregulation of Srx, TXNDC5, or PDIA6 significantly reduced cell viability in response to tunicamycin treatment. TXNDC5 knockdown decreased the time required for the splicing of X-box binding protein-1 (XBP-1). In either knockdown Srx or TXNDC5 cells, there was an observable decrease in the expression of GRP78 and the splicing of spliced XBP-1. These results suggest a possible role of Srx in unfolded protein response signaling. TXNDC5 and PDIA6, similar to Srx, contribute to the proliferation, anchorage independent colony formation and migration of lung cancer cells. In this dissertation I concluded that Srx TXNDC5, and PDIA6 proteins participate in oxidative protein folding in lung cancer. Srx and TXNDC5 can modulate unfolded protein response (UPR) sensor activation and growth inhibition. Furthermore, TXNDC5 and PDIA6 can promote tumorigenesis of lung cancer cells. Therefore, the molecular interaction of Srx with TXNDC5/PDIA6 has the potential to be used as novel therapeutic targets for lung cancer treatment.

Plantas transgênicas constituem interessantes alternativas para a produção de compostos com elevado valor agregado como polímeros industriais, proteínas farmacológicas e lipídios nutracêuticos. Como candidata à biofábrica, a cana-de-açúcar (Saccharum spp.) apresenta características agronômicas favoráveis, além de versatilidade de matéria-prima, que é empregada em fins tradicionais, como produção de álcool e açúcar, e até mesmo para geração de energia ou como forragem para alimentação de gado. Em nutrição animal, uma molécula bastante estudada é o ácido linoleico conjugado (CLA), que tem atividades anticarcinogênica, antidiabética, antiaterosclerose e moduladora do sistema imune e metabolismo de lipídios. O isômero t10,c12- CLA tem sido particularmente promissor na agropecuária por conta de inibição da síntese de gordura do leite e na melhoria do desempenho reprodutivo de vacas. Com o objetivo de avaliar a cana-de-açúcar como sistema biotecnológico para produção de CLA, o gene da isomerase do ácido linoleico de Propionibacterium acnes (pai) foi isolado e clonado, previamente caracterizado em Escherichia coli e, em seguida, utilizado na biolística de calos embriogênicos para regeneração de plantas transgênicas. No sistema procariótico, foi induzida a expressão de pai e a proteína heteróloga foi verificada como uma banda de 50 kDa, porém não houve alteração evidente do perfil de ácidos graxos da bactéria. Na cotransformação de cana-de-açúcar, o vetor pHA9, que contém o gene de seleção da neomicina fosfotransferase (nptII), foi bombardeado com uma das duas construções desenvolvidas com o promotor da poliubiquitina 1 de milho (pUbi1) dirigindo a expressão de pai adicionado ou não de sequência sinal da proteína de reparo de DNA recA para direcionamento para cloroplasto. Das cultivares CTC2 e IACSP9303046, foram obtidas eficiências de transformações de 2,2% e 1,7-7,1%, respectivamente. Um total de 156 plântulas foram regeneradas após regime de seleção com geneticina. Em seguida, 115 plântulas transgênicas foram identificadas por PCR para nptII e, entre essas, 29 e 48 foram PCRpositivas para pai e rec-pai, respectivamente. De 50 plantas aclimatizadas, 12 foram analisadas por Southern blot para nptII e 4 para pai, confirmando-se a transformação genética. Para comprovar a expressão de mRNA de pai, 27 plantas foram averiguadas por RT-PCR e RT-qPCR e indicaram produção de transcritos estudados. A análise de expressão das proteínas de folha por Western blot em 21 plantas selecionadas não produziu resultados conclusivos quanto à detecção de PAI. Essas mesmas foram analisadas por Cromatografia Gasosa, mas não foi detectado acúmulo de CLA. Embora seja possível a introdução e expressão do gene pai em cana-de-açúcar, é necessário avaliar em maior detalhe os fatores que possam afetar positivamente a produção de CLA, como tipo de tecido, compartimentos subcelulares para direcionamento proteico ou coexpressão de fosfolipases. / Transgenic plants are attractive alternatives for the production of high value compounds as industrial polymers, pharmacological proteins and nutraceutical lipids. As a candidate for biofactory, sugarcane presents favorable agronomic characteristics and versatility of raw material which is used for traditional purposes such as ethanol and sugar production and even for power generation or as forage feeding of cattle. In animal nutrition, a widely studied molecule is the conjugated linoleic acid (CLA), which has anticarcinogenic, antidiabetic, antiatherosclerosis and immune system and metabolism of lipids modulator activities. The isomer t10,c12-CLA has been particularly promising in agriculture because of inhibition of milk fat synthesis and improvement of the reproductive performance of cows. Aiming to evaluate the sugarcane as a system for biotechnological production of CLA, the linoleic acid isomerase gene from Propionibacterium acnes (pai) was isolated and cloned, previously characterized in Escherichia coli and then used for biolistic of embryogenic calli for regenerating transgenic plants. In the prokaryotic system, the expression of pai was induced and the heterologous protein was verified as a band of 50 kDa, but there was no obvious change in fatty acid profile of the bacterium. In cotransformation of sugarcane, pHA9 vector containing the selection gene neomycin phosphotransferase (nptII) was bombarded with one of the two constructions developed with the promoter of maize polyubiquitin 1 (pUbi1) driving the expression of pai, either added or not with the signal sequence of DNA repair protein recA for targeting to chloroplast. Cultivars CTC2 and IACSP93-3046 were obtained with transformation efficiencies of 2.2% and 1.7 a 7.1%, respectively. A total of 156 plantlets were regenerated after selection with geneticin regimen. After that, 115 transgenic plantlets were identified by PCR for nptII and among then, 29 and 48 were PCR-positive for pai and rec-pai, respectively. Of 50 acclimatized plants, 12 were analyzed by Southern blot for nptII and 4 for pai, confirming the genetic transformation. In order to prove the expression of pai mRNA, 27 plants were verified by RT-PCR and RT-qPCR and indicated the production of the studied transcripts. Expression analysis of leaf proteins by Western blot in 21 plants selected produced no conclusive results regarding the detection of PAI. Those were analyzed by gas chromatography and no accumulation of CLA was detected. Although it was possible to introduce and express the pai gene in sugarcane, it is necessary to evaluate in more detail the factors that may positively affect the production of CLA, as tissue type, subcellular compartments for protein targeting or coexpression of phospholipases.

A Síndrome de Marfan (SMF) é a enfermidade hereditária mais comum dentre as que afetam o sistema conjuntivo, causada por mutações da glicoproteína fibrilina-1, o principal componente estrutural das microfibrilas elásticas da matriz extracelular. As manifestações fenotípicas da SMF são sistêmicas e acometem tipicamente os sistemas ocular, esquelético e cardiovascular, este uma importante causa de morbi-mortalidade. Entretanto, não está claro como a mutação induz a doença. Estudos anteriores sugerem anomalias morfológicas do retículo endoplasmático (RE) ou retenção intracelular da fibrilina-1 nos estágios avançados da SMF. Entretanto, a contribuição do enovelamento da fibrilina-1 mutada e do estresse do RE na fisiopatologia celular da SMF não é conhecida. Proteínas mal-enoveladas podem levar à retenção intracelular e/ou aumento da degradação através da via de degradação associada ao RE (ERAD), além da indução da resposta a proteínas mal-enoveladas (UPR), ambas com potencial contribuição à fisiopatologia de doenças, incluindo a SMF. Assim, estudamos em fibroblastos embrionários isolados de camundongos (MEFs) com SMF se a fibrilina-1 mutada é reconhecida pelo controle de qualidade do RE pelo seu mal- enovelamento e induz estresse do RE por sua retenção intracelular. Demonstramos que a mutação na fibrilina-1 per se não promoveu chaperonas marcadoras de UPR ou geração de oxidantes. Além disso, não levou a uma maior sensibilização das células à indução exógena de estresse do RE, nem promoveu maior morte celular após inibição do proteassoma. Além disso, não foi observada retenção intracelular da fibrilina-1 nas células SMF, e mesmo após inibição da via secretora ou indução de estresse do RE, a inibição da secreção da fibrilina-1 foi similar nos MEFs SMF e wild-type (WT). A dissulfeto isomerase proteica (PDI), uma importante chaperona redox do RE, interage com fibrilina-1, e seu silenciamento levou a um aumento na secreção da fibrilina-1 pelos MEFs WT, mas não SMF. Além disso, o silenciamento da PDI promoveu a desorganização da matriz extracelular depositada de fibrilina-1 nos MEFs WT, enquanto nos MEFs SMF, a desorganização basal da matriz não foi adicionalmente alterada. Em paralelo, investigações in vivo mostraram que o estresse do RE não é induzido em camundongos SMF com 1 ou 3 meses de idade, apesar de manifestações fenotípicas evidentes. Entretanto, concomitante à progressão da doença, detectamos a ocorrência de estresse do RE nas aortas ascendentes dos camundongos aos 6 meses. Esta detecção foi exclusiva desta região da aorta e não ocorreu em outros órgãos afetados ou não afetados pela SMF. Assim, a manifestação do fenótipo clássico da SMF não requer uma perda da homeostase do RE diretamente induzida pela fibrilina-1 mutada. Ao contrário, esta é capaz de evadir mecanismos de controle de qualidade mediados pela PDI, sendo secretada normalmente. Assim, esta evasão do controle de qualidade pela PDI é uma condição permissiva essencial para o fenótipo da SMF. Por outro lado, o estresse do RE é uma característica evolutiva do aneurisma da aorta ascendente na SMF concomitante ao agravamento do fenótipo neste tecido / Marfan syndrome (MFS) is the most common connective tissue hereditary disease, caused by mutations in the glycoprotein fibrillin-1, the main structural component of extracellular matrix elastic microfibrils. MFS phenotypic manifestations are systemic and typically involve the ocular, skeletal and cardiovascular systems, the latter a major cause of morbidity/mortality. However, how gene mutation induxes disease is yet unclear. Previous studies suggest endoplasmic reticulum (ER) morphological abnormalities or fibrillin-1 intracellular retention in advanced MFS stages. However, the contribution of mutated fibrillin-1 folding and ER stress to MFS cellular pathophysiology is unknown. Un/misfolded proteins may associate with their intracellular retention and/or increased degradation through ER-associated degradation (ERAD), in addition to inducing the unfolded protein response (UPR), both sharing potential contributions to disease pathophysiology, including MFS. Thus, we studied in embryonic fibroblasts (MEFs) isolated from WT and MFS mice, if mutated fibrillin-1 can be recognized by ER quality control as a misfolded protein, able to induce ER stress due to its intracellular retention. We showed that fibrillin-1 mutation by itself did not promote UPR chaperone markers or oxidant generation. Moreover, it did not sensitize cells to exogenous ER stress nor affected cell survival curves after proteasome inhibition. Furthermore, no intracellular retention of fibrillin-1 was observed in MFS cells, and even after secretory pathway inhibition or ER stress induction, fibrillin-1 secretion inhibition was similar in MFS and wild-type (WT) MEFs. Protein disulfide isomerase (PDI), an important ER redox chaperone, interacts with fibrillin-1 and its silencing induced an increased fibrillin-1 secretion in WT, but not MFS MEFs. Besides, PDI silencing promoted fibrillin-1 extracellular matrix disorganization in WT MEFs, whereas in MFS MEFs, the basal matrix disorganization was not further modified. Parallel in vivo evaluations demonstrated that ER stress is also not induced in 1 and 3 month-old mice MFS, despite evident phenotypical manifestations. However, concomitant to accelerated disease progression at 6 months, ER stress was detectable in ascendant aorta, but not in other disease-affected or unaffected organs. Thus, classic MFS phenotype manifestations do not require loss of ER homeostasis directly induced by mutated fibrillin-1. Contrarily, the latter can evade a PDI-mediated quality control mechanism to be normally secreted. Therefore, evading such PDI-mediated quality control is an essential permissive condition for enabling the MFS phenotype. On the other hand, ER stress is an evolutive feature of MFS ascendant aorta aneurysm concomitant to phenotype progression in this tissue